Because aberrant activation of the PI3K/AKT pathway has been shown to promote the drug resistance ability of PC cells 24, we next evaluated whether Rhein can potentiate the effect of oxaliplatin in these cell lines. Here, AKT1 is linked to pachyonychia congenita.